STOCK TITAN

[Form 4] CAMDEN NATIONAL CORP Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Rebecca Hatfield, a director of Camden National Corporation (CAC), acquired 245 shares of the issuer's common stock on 09/19/2025 at a price of $40.22 per share. The purchase was made under Camden National Corporation's 2022 Equity and Incentive Plan and was issued in lieu of director fees. Following the transaction, the filing reports 7,177.06 shares beneficially owned by the reporting person. The Form 4 was signed by a power of attorney, Christopher G. Hutchinson, on 09/23/2025.

Rebecca Hatfield, direttore della Camden National Corporation (CAC), ha acquistato 245 azioni ordinarie dell’emittente il 19/09/2025 al prezzo di €40,22 per azione. L’acquisto è stato effettuato nell’ambito del 2022 Equity and Incentive Plan della Camden National Corporation ed è stato emesso in luogo delle commissioni da amministratore. Dopo la transazione, la dichiarazione riporta 7.177,06 azioni possedute beneficiariamente dalla persona che presenta il dato. Il Form 4 è stato firmato da una procura, Christopher G. Hutchinson, 23/09/2025.

Rebecca Hatfield, directora de Camden National Corporation (CAC), adquirió 245 acciones ordinarias del emisor el 19/09/2025 a un precio de $40,22 por acción. La compra se realizó bajo el Plan de Acciones y Incentivos 2022 de Camden National Corporation y se emitió en lugar de honorarios de director. Tras la operación, el formulario reporta 7.177,06 acciones en beneficio de la persona reportante. El Formulario 4 fue firmado por poder legal, Christopher G. Hutchinson, el 23/09/2025.

Rebecca Hatfield는 Camden National Corporation(CAC)의 이사로서 2025-09-19에 주당 $40.22의 가격으로 발행주식 245주를 매입했습니다. 이 매수는 Camden National Corporation의 2022 Equity and Incentive Plan에 따라 이루어졌으며 이사회 수수료 대신으로 지급되었습니다. 거래 후 보고서는 7,177.06주를 유익하게 보유한다고 보고합니다. Form 4Christopher G. Hutchinson의 대리인에 의해 2025-09-23에 서명되었습니다.

Rebecca Hatfield, directrice de Camden National Corporation (CAC), a acquis 245 actions ordinaires de l’émetteur le 19/09/2025 à un prix de 40,22 $ par action. Cet achat a été effectué dans le cadre du plan d’actionnariat et d’incitation 2022 de Camden National Corporation et a été émis en lieu et place des frais de directeur. Après la transaction, le formulaire indique 7.177,06 actions détenues par la personne déclarante. Le Formulaire 4 a été signé par pouvoir, Christopher G. Hutchinson, le 23/09/2025.

Rebecca Hatfield, Direktorin der Camden National Corporation (CAC), erwarb am 19.09.2025 245 Stammaktien des Emittenten zum Preis von 40,22 $ pro Aktie. Der Kauf erfolgte im Rahmen des 2022 Equity and Incentive Plan der Camden National Corporation und wurde als Ersatz für Direktorengebühren ausgegeben. Nach der Transaktion meldet die Einreichung 7.177,06 Aktien, die von der meldenden Person vorteilhaft gehalten werden. Das Formular 4 wurde von einer Vollmacht, Christopher G. Hutchinson, am 23.09.2025 unterzeichnet.

ريبيكا هاتفيلد، مديرة في Camden National Corporation (CAC)، اشترت 245 سهماً من أسهم الشركة المصدرة العادية في 19/09/2025 بسعر $40.22 للسهم الواحد. تمت الصفقة بموجب خطة الأسهم والحوافز 2022 لدى Camden National Corporation وأُصدرت بدلاً من أتعاب المدير. بعد المعاملة، تُبلغ الإيداع عن امتلاك الشخص المبلغ 7,177.06 سهماً لفائدة المبلغ. تم توقيع نموذج 4 بواسطة الوصي المفوض، Christopher G. Hutchinson، في 23/09/2025.

Rebecca Hatfield,Camden National Corporation(CAC)的董事,在 2025-09-19 以每股 $40.22 美元的价格购买了 245 股发行人的普通股。此次购买是根据 Camden National Corporation 的 2022 年股权与激励计划 进行的,作为董事费的替代。交易完成后,申报人持有的受益股数为 7,177.06 股。Form 4 由授权代理人 Christopher G. Hutchinson2025-09-23 签署。

Positive
  • Increases director alignment with shareholders by converting director fees into equity under the 2022 Equity and Incentive Plan
  • Transparent disclosure of transaction date, price, plan source, and post-transaction beneficial ownership
Negative
  • None.

Insights

TL;DR: Routine insider equity grant/purchase that modestly increases director alignment with shareholders.

The Form 4 documents a non-derivative acquisition of 245 common shares at $40.22 each under the company's 2022 Equity and Incentive Plan, issued in lieu of director fees. This is a standard compensation-related issuance rather than a market purchase, so it primarily reflects compensation policy and alignment rather than a director-driven market signal. The post-transaction beneficial ownership figure of 7,177.06 shares provides context for Hatfield's stake but lacks company-wide outstanding share data to assess scale. Impact on valuation or control is immaterial based on the limited size disclosed.

TL;DR: Typical director compensation transaction; governance practice appears consistent with equity-based pay for non-employee directors.

Issuing equity in lieu of director fees under an approved equity plan is a common governance practice to align directors with shareholder interests. The Form 4 properly discloses the transaction date, price, plan source, and beneficial ownership after the transaction. The POA signature indicates administrative processing; there is no indication of accelerated vesting, options, or derivative activity. Without additional filings or material departures from plan terms, this item represents routine governance administration.

Rebecca Hatfield, direttore della Camden National Corporation (CAC), ha acquistato 245 azioni ordinarie dell’emittente il 19/09/2025 al prezzo di €40,22 per azione. L’acquisto è stato effettuato nell’ambito del 2022 Equity and Incentive Plan della Camden National Corporation ed è stato emesso in luogo delle commissioni da amministratore. Dopo la transazione, la dichiarazione riporta 7.177,06 azioni possedute beneficiariamente dalla persona che presenta il dato. Il Form 4 è stato firmato da una procura, Christopher G. Hutchinson, 23/09/2025.

Rebecca Hatfield, directora de Camden National Corporation (CAC), adquirió 245 acciones ordinarias del emisor el 19/09/2025 a un precio de $40,22 por acción. La compra se realizó bajo el Plan de Acciones y Incentivos 2022 de Camden National Corporation y se emitió en lugar de honorarios de director. Tras la operación, el formulario reporta 7.177,06 acciones en beneficio de la persona reportante. El Formulario 4 fue firmado por poder legal, Christopher G. Hutchinson, el 23/09/2025.

Rebecca Hatfield는 Camden National Corporation(CAC)의 이사로서 2025-09-19에 주당 $40.22의 가격으로 발행주식 245주를 매입했습니다. 이 매수는 Camden National Corporation의 2022 Equity and Incentive Plan에 따라 이루어졌으며 이사회 수수료 대신으로 지급되었습니다. 거래 후 보고서는 7,177.06주를 유익하게 보유한다고 보고합니다. Form 4Christopher G. Hutchinson의 대리인에 의해 2025-09-23에 서명되었습니다.

Rebecca Hatfield, directrice de Camden National Corporation (CAC), a acquis 245 actions ordinaires de l’émetteur le 19/09/2025 à un prix de 40,22 $ par action. Cet achat a été effectué dans le cadre du plan d’actionnariat et d’incitation 2022 de Camden National Corporation et a été émis en lieu et place des frais de directeur. Après la transaction, le formulaire indique 7.177,06 actions détenues par la personne déclarante. Le Formulaire 4 a été signé par pouvoir, Christopher G. Hutchinson, le 23/09/2025.

Rebecca Hatfield, Direktorin der Camden National Corporation (CAC), erwarb am 19.09.2025 245 Stammaktien des Emittenten zum Preis von 40,22 $ pro Aktie. Der Kauf erfolgte im Rahmen des 2022 Equity and Incentive Plan der Camden National Corporation und wurde als Ersatz für Direktorengebühren ausgegeben. Nach der Transaktion meldet die Einreichung 7.177,06 Aktien, die von der meldenden Person vorteilhaft gehalten werden. Das Formular 4 wurde von einer Vollmacht, Christopher G. Hutchinson, am 23.09.2025 unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hatfield Rebecca

(Last) (First) (Middle)
2 ELM STREET
P.O. BOX 310

(Street)
CAMDEN ME 04843

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CAMDEN NATIONAL CORP [ CAC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/19/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/19/2025 A 245(1) A $40.22 7,177.06 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Shares acquired under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment in lieu of director fees.
Remarks:
Christopher G. Hutchinson, POA 09/23/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Rebecca Hatfield report on Form 4 for CAC?

The Form 4 reports an acquisition of 245 common shares on 09/19/2025 at $40.22 per share, issued under the company's 2022 Equity and Incentive Plan in lieu of director fees.

How many shares does the reporting person beneficially own after the transaction?

The filing reports 7,177.06 shares beneficially owned following the reported transaction.

Was the transaction a market purchase or an issuance under a plan?

The shares were issued under the 2022 Equity and Incentive Plan and granted in lieu of director fees, not a market open-market purchase.

Who signed the Form 4 and when was it signed?

The Form 4 was signed by power of attorney Christopher G. Hutchinson on 09/23/2025.

Does the filing show any derivative transactions (options, warrants) for the reporting person?

No. Table II for derivative securities shows no entries; the reported transaction is a non-derivative common stock acquisition.
Camden Natl Corp

NASDAQ:CAC

CAC Rankings

CAC Latest News

CAC Latest SEC Filings

CAC Stock Data

652.45M
16.57M
1.78%
73.89%
2.76%
Banks - Regional
National Commercial Banks
Link
United States
CAMDEN